Search research articles
Contact Us
Filters
Showing results (101-110 of 113) with videos related to
Page
of 12
Sort By:
Plos One
|
July 30, 2021
Development and validation of a prognostic 40-day mortality risk model among hospitalized patients with COVID-19
Donald A Berry, Andrew Ip, Brett E Lewis, et al.
Clinical Trials (London, England)
|
August 21, 2020
Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial
Brett L Houston, Patrick R Lawler, Ewan C Goligher, et al.
American Journal of Respiratory and Critical Care Medicine
|
October 10, 2009
Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial
Mario Castro, Adalberto S Rubin, Michel Laviolette, et al.
Plos One
|
August 14, 2020
Hydroxychloroquine and tocilizumab therapy in COVID-19 patients-An observational study
Andrew Ip, Donald A Berry, Eric Hansen, et al.
JAMA
|
October 3, 2019
Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock: The SEPSIS-ACT Randomized Clinical Trial
Pierre-Francois Laterre, Scott M Berry, Allan Blemings, et al.
JAMA Network Open
|
May 25, 2023
Effect of P2Y12 Inhibitors on Organ Support-Free Survival in Critically Ill Patients Hospitalized for COVID-19: A Randomized Clinical Trial
Jeffrey S Berger, Matthew D Neal, Lucy Z Kornblith, et al.
Nature Medicine
|
June 22, 2021
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease
Stephen Salloway, Martin Farlow, Eric McDade, et al.
JAMA Oncology
|
July 24, 2020
Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial
, Douglas Yee, Angela M DeMichele, et al.
The New England Journal of Medicine
|
October 27, 2023
Simvastatin in Critically Ill Patients with Covid-19
, Thomas E Hills, Elizabeth Lorenzi, et al.
Journal of Thrombosis and Haemostasis : JTH
|
March 27, 2026
Intermediate Dose Heparin Thromboprophylaxis among Critically Ill Patients with COVID-19: A Randomised Clinical Trial
, Charlotte A Bradbury, Bryan J McVerry, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 113) with videos related to
Sort By:
Page
of 12
Plos One
|
July 30, 2021
Development and validation of a prognostic 40-day mortality risk model among hospitalized patients with COVID-19
Donald A Berry, Andrew Ip, Brett E Lewis, et al.
Clinical Trials (London, England)
|
August 21, 2020
Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial
Brett L Houston, Patrick R Lawler, Ewan C Goligher, et al.
American Journal of Respiratory and Critical Care Medicine
|
October 10, 2009
Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial
Mario Castro, Adalberto S Rubin, Michel Laviolette, et al.
Plos One
|
August 14, 2020
Hydroxychloroquine and tocilizumab therapy in COVID-19 patients-An observational study
Andrew Ip, Donald A Berry, Eric Hansen, et al.
JAMA
|
October 3, 2019
Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock: The SEPSIS-ACT Randomized Clinical Trial
Pierre-Francois Laterre, Scott M Berry, Allan Blemings, et al.
JAMA Network Open
|
May 25, 2023
Effect of P2Y12 Inhibitors on Organ Support-Free Survival in Critically Ill Patients Hospitalized for COVID-19: A Randomized Clinical Trial
Jeffrey S Berger, Matthew D Neal, Lucy Z Kornblith, et al.
Nature Medicine
|
June 22, 2021
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease
Stephen Salloway, Martin Farlow, Eric McDade, et al.
JAMA Oncology
|
July 24, 2020
Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial
, Douglas Yee, Angela M DeMichele, et al.
The New England Journal of Medicine
|
October 27, 2023
Simvastatin in Critically Ill Patients with Covid-19
, Thomas E Hills, Elizabeth Lorenzi, et al.
Journal of Thrombosis and Haemostasis : JTH
|
March 27, 2026
Intermediate Dose Heparin Thromboprophylaxis among Critically Ill Patients with COVID-19: A Randomised Clinical Trial
, Charlotte A Bradbury, Bryan J McVerry, et al.
Page
of 12